EuroIntervention

Scope & Guideline

Empowering Healthcare Professionals with Cutting-Edge Knowledge

Introduction

Immerse yourself in the scholarly insights of EuroIntervention with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1774-024x
PublisherEUROPA EDITION
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2008 to 2024
AbbreviationEUROINTERVENTION / EuroIntervention
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address19 ALLEES JEAN JAURES B P 61508, TOULOUSE CEDEX 6 31015, FRANCE

Aims and Scopes

EuroIntervention focuses on advancing the field of interventional cardiovascular medicine, particularly through innovative techniques and devices for managing coronary and valvular heart diseases.
  1. Transcatheter Aortic Valve Implantation (TAVI):
    The journal frequently publishes studies on TAVI, exploring its effectiveness, complications, and advancements in valve technology.
  2. Percutaneous Coronary Intervention (PCI):
    Research on PCI techniques, including stenting, drug-coated balloons, and the management of complications, is a core focus area.
  3. Innovative Devices and Techniques:
    The journal highlights novel devices and methodologies, such as robotic assistance in procedures, and new stent technologies.
  4. Clinical Outcomes and Predictive Models:
    Studies assessing the long-term outcomes of various interventions and the development of predictive models for patient outcomes are prevalent.
  5. Antithrombotic Therapy:
    Exploration of antithrombotic strategies, including dual antiplatelet therapy (DAPT) and its implications in different patient populations.
  6. Valvular Heart Disease Interventions:
    Research on interventions for mitral and tricuspid valve diseases, including edge-to-edge repair techniques, is also prominent.
EuroIntervention has identified several emerging research themes that reflect the current trends in interventional cardiovascular medicine, driven by technological advancements and evolving clinical practices.
  1. Hybrid Approaches to Treatment:
    There is a growing interest in hybrid therapies that combine surgical and percutaneous methods, particularly in complex cases involving multi-valvular disease.
  2. Use of Artificial Intelligence (AI):
    AI applications in predicting outcomes, optimizing procedures, and enhancing imaging analysis are increasingly featured in recent publications.
  3. Patient-Centric Approaches:
    Research focusing on patient-reported outcomes, shared decision-making, and personalized treatment plans is on the rise, emphasizing the importance of patient preferences in clinical practice.
  4. Long-term Durability of Devices:
    Studies investigating the long-term performance and outcomes of newer devices, especially bioresorbable scaffolds and advanced stenting platforms, are gaining traction.
  5. Management of Non-Obstructive Coronary Artery Disease (MINOCA):
    An increasing number of studies are focusing on the diagnosis and management strategies for MINOCA, reflecting a shift towards understanding this complex condition.

Declining or Waning

While EuroIntervention continues to thrive in many areas, certain themes have seen a decline in prominence, reflecting shifts in clinical practice and research focus.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in publications focused solely on traditional surgical interventions, as the field shifts towards less invasive, transcatheter approaches.
  2. Conventional Imaging Techniques:
    Research dedicated to older imaging modalities is waning in favor of advanced intravascular imaging techniques like optical coherence tomography (OCT) and intravascular ultrasound (IVUS).
  3. General Antithrombotic Guidelines:
    Specific guidelines that do not account for individual patient risk profiles are becoming less common, as personalized medicine approaches gain traction.
  4. Single Antiplatelet Therapy:
    There is a declining emphasis on the use of single antiplatelet therapy, especially in high-risk populations, with more focus on tailored DAPT strategies.
  5. Pharmacological Approaches in Isolation:
    Research that does not integrate procedural techniques with pharmacological management is becoming less frequent, as a more holistic approach is favored.

Similar Journals

Journal fur Kardiologie

Nurturing Progress in Cardiovascular Medicine.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Anatolian Journal of Cardiology

Bridging Knowledge Gaps in Cardiology for a Healthier Tomorrow.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Kardiologie

Innovating Heart Health: Where Research Meets Clinical Practice.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7129Frequency: 6 issues/year

Kardiologie is an emerging journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by SPRINGER HEIDELBERG in Germany. Established with the first issue in 2022, this journal provides a valuable platform for the dissemination of innovative research, clinical studies, and review articles that contribute to both theoretical knowledge and practical applications in cardiology. While the journal currently holds a Q4 category ranking in the field and occupies a percentile of 24 according to Scopus, it aims to enhance its impact factor by attracting high-quality submissions from researchers and clinicians alike. Kardiologie is particularly focused on bridging the gap between cutting-edge research and clinical practice, ensuring that the latest scientific findings are readily accessible to practitioners. Though it operates under traditional access options at present, the journal aspires to broaden its accessibility and reach in future editions, making it a pertinent choice for anyone interested in the evolving landscape of cardiovascular health.

Cardiology Journal

Advancing cardiovascular knowledge without barriers.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Vasa-European Journal of Vascular Medicine

Elevating Vascular Medicine Through Innovative Research
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 0301-1526Frequency: 6 issues/year

Vasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.

JOURNAL OF INVASIVE CARDIOLOGY

Connecting Professionals to the Latest in Cardiac Innovation
Publisher: H M P COMMUNICATIONSISSN: 1042-3931Frequency: 12 issues/year

JOURNAL OF INVASIVE CARDIOLOGY, a reputable publication by H M P COMMUNICATIONS, is dedicated to advancing the field of cardiology and cardiovascular medicine through rigorous research and scholarly discussion. With an ISSN of 1042-3931 and an E-ISSN of 1557-2501, this journal serves as a crucial resource for healthcare professionals, researchers, and students who seek to stay informed about the latest findings and innovations in invasive cardiology. Having achieved a 2023 Scopus rank of #185 out of 636 in General Medicine, placing it in the 70th percentile, the journal is recognized for its significant contributions to medical science, evidenced by its Q2 ranking in Radiology, Nuclear Medicine and Imaging, and Q3 status in both Cardiology and Cardiovascular Medicine. The journal has been in circulation since 1990 and continues to foster a platform for critical research in the United States, ensuring accessibility to vital information necessary for enhancing patient care and clinical practices within the domain of invasive procedures.

Cardiovascular Intervention and Therapeutics

Advancing cardiovascular care through innovative research.
Publisher: SPRINGER JAPAN KKISSN: 1868-4300Frequency: 4 issues/year

Cardiovascular Intervention and Therapeutics, published by SPRINGER JAPAN KK, stands as a prominent journal within the fields of cardiology and cardiovascular medicine, reflecting its commitment to disseminating groundbreaking research and clinical advances. With an impressive Q2 ranking in Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous), and a Q1 ranking in Radiology, Nuclear Medicine and Imaging, this journal employs rigorous peer-review processes to ensure the quality and relevance of its content. Catering to a diverse audience of researchers, clinicians, and students, the journal aims to foster innovation and enhance understanding through the publication of original research, reviews, and clinical studies focused on cardiovascular interventions and therapies. Spanning over a decade of evolution from 2010 to 2024, Cardiovascular Intervention and Therapeutics continues to be a vital resource for advancing knowledge and practice in the cardiovascular field. Explore the latest advancements and insights that this esteemed journal has to offer, and contribute to the ongoing dialogue that shapes modern cardiovascular medicine.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Leading the Charge in Cardiovascular Innovation and Excellence
Publisher: WILEYISSN: 1522-1946Frequency: 14 issues/year

Catheterization and Cardiovascular Interventions is a leading peer-reviewed journal published by Wiley, dedicated to advancing the fields of cardiology, cardiovascular medicine, and radiology. With an impressive impact factor and categorized in the Q1 quartile across multiple disciplines—including Cardiology, Medicine, and Radiology—this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in minimally invasive techniques and innovative cardiovascular therapies. Since its inception in 1999 and continuing through 2024, Catheterization and Cardiovascular Interventions has provided a platform for high-quality original research, reviews, and case studies, highlighting approaches that improve patient outcomes and treatment methodologies. Operating from the United States, the journal offers various access options, making key findings in cardiovascular interventions readily available to its audience. Stay at the forefront of cardiovascular innovation by engaging with this pivotal publication.

ACTA CARDIOLOGICA

Pioneering insights in cardiology and cardiovascular medicine.
Publisher: TAYLOR & FRANCIS LTDISSN: 0001-5385Frequency: 6 issues/year

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Heart International

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.